SGLT2 Inhibitors in Cardio-Kidney-Metabolic Syndrome

Presented by: Rabih Dandachi, MD, FACC Diala Najjar, PharmD, BCPS Cardio-kidney-metabolic syndrome highlights the close interconnection between cardiovascular disease, chronic kidney disease, and metabolic disorders. SGLT2 inhibitors have emerged as an important therapeutic class within this continuum, with an expanding role in the management of patients across cardiovascular, renal, and metabolic conditions. In this educational webinar, Rabih Dandachi, MD, FACC, and Diala Najjar, PharmD, BCPS, discuss the role of SGLT2 inhibitors in cardio-kidney-metabolic syndrome, exploring their clinical relevance and the importance of an integrated approach to patient care. In this webinar, you will learn: The concept of cardio-kidney-metabolic syndrome and the interrelationship between cardiovascular, renal, and metabolic disease The role of SGLT2 inhibitors within the cardio-kidney-metabolic continuum The clinical benefits associated with SGLT2 inhibitor therapy across relevant patient populations Key considerations when identifying patients who may benefit from SGLT2 inhibitors Important safety considerations and precautions associated with SGLT2 inhibitor therapy The importance of appropriate patient counseling and treatment adherence How multidisciplinary care can help optimize outcomes in patients with interconnected cardiovascular, renal, and metabolic conditions The pharmacist’s role in patient education, medication management, monitoring, and supporting appropriate use of SGLT2 inhibitors This webinar is intended for pharmacists, pharmacy students, and other healthcare professionals interested in strengthening their understanding of SGLT2 inhibitors and their evolving role in cardio-kidney-metabolic care. This educational webinar was organized by the OPL Scientific Committee and supported by Boehringer Ingelheim. If you found this webinar helpful, don't forget to Like, Subscribe, and Share to stay updated with our latest educational content. For more educational activities and upcoming webinars, follow the Order of Pharmacists of Lebanon channel. #SGLT2Inhibitors #CardioKidneyMetabolic #CardiovascularHealth #KidneyHealth #MetabolicHealth #HeartFailure #ChronicKidneyDisease #Diabetes #ClinicalPharmacy #Pharmacists #PharmacyEducation #PatientCare #HealthcareProfessionals #OrderofPharmacistsofLebanon #OPLScientificActivities #BoehringerIngelheim #SciencePRO